Dr. Michael Kalafatis at Cleveland State University in Cleveland, Ohio has discovered that the casein kinase II inhibitor DMAT powerfully and effectively kills all human cancer cell lines in xenograft studied performed on mice at the Taussig Research Center of the Cleveland Clinic. This treatment must be rushed through clinical trials (and funding granted) so the harmless drug can reach the bedside by the end of 2012.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
